Fmr LLC Collegium Pharmaceutical, Inc Transaction History

Fmr LLC

$1.68 Trillion
Q2 2025

A detailed history of Fmr LLC transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Fmr LLC holds 52,559 shares of COLL stock, worth $1.68 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

52,559

Previous 50,286 4.52%

Holding current value

$1.68 Million

Previous $1.5 Million 3.53%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$24.67 - $30.44 $56,074 - $69,190	2,273 Added 4.52%	52,559 $1.55 Million
Q1 2025 May 12, 2025	SELL	$28.04 - $33.91 $261,360 - $316,075	-9,321 Reduced 15.64%	50,286 $1.5 Million
Q4 2024 Feb 13, 2025	BUY	$28.61 - $41.86 $625,271 - $914,850	21,855 Added 57.89%	59,607 $1.71 Million
Q3 2024 Nov 13, 2024	BUY	$31.4 - $39.07 $1.11 Million - $1.38 Million	35,439 Added 1532.17%	37,752 $1.46 Million
Q2 2024 Aug 13, 2024	SELL	$31.36 - $39.99 $12,638 - $16,115	-403 Reduced 14.84%	2,313 $74,000
Q1 2024 May 13, 2024	BUY	$31.23 - $40.91 $2,404 - $3,150	77 Added 2.92%	2,716 $105,000
Q4 2023 Feb 13, 2024	BUY	$21.16 - $30.8 $1,756 - $2,556	83 Added 3.25%	2,639 $81,000
Q3 2023 Nov 13, 2023	BUY	$21.23 - $24.28 $6,029 - $6,895	284 Added 12.5%	2,556 $57,000
Q2 2023 Aug 11, 2023	SELL	$21.06 - $24.0 $1,137 - $1,296	-54 Reduced 2.32%	2,272 $48,000
Q1 2023 May 11, 2023	BUY	$23.0 - $29.88 $7,406 - $9,621	322 Added 16.07%	2,326 $55,000
Q4 2022 Feb 13, 2023	SELL	$16.14 - $23.55 $581 - $847	-36 Reduced 1.76%	2,004 $46,000
Q3 2022 Nov 10, 2022	SELL	$15.46 - $20.1 $4,993 - $6,492	-323 Reduced 13.67%	2,040 $32,000
Q2 2022 Aug 12, 2022	BUY	$14.22 - $20.88 $1,777 - $2,610	125 Added 5.59%	2,363 $42,000
Q1 2022 May 13, 2022	BUY	$17.2 - $22.5 $22,635 - $29,610	1,316 Added 142.73%	2,238 $46,000
Q2 2021 Aug 13, 2021	BUY	$21.74 - $25.28 $20,044 - $23,308	922 New	922 $21,000

Others Institutions Holding COLL

# of Institutions

242

Shares Held

36.4M

Call Options Held

52.5K

Put Options Held

200

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.09B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account